The Valens Company Receives Additional Product Listings with SQDC

3.9 min readPublished On: June 16th, 2022By

KELOWNA, BC – The Valens Company Inc. (TSX: VLNS) (NASDAQ: VLNS), a manufacturer of branded cannabis products, today announced the launch of a Quebec-exclusive brand, Bon Jak. Valens continues to build its presence in Quebec with the addition of several exciting new SKUs under the Bon Jak brand, which is focused on delivering unique user experiences in the province of Quebec:

Dried Flower:

Bon Jak BC God Bud (28g)
Bon Jak Indica Ground (15g)
Bon Jak Sativa Ground (15g)

Cannabis-Infused Beverages:

Bon Jak Lime Seltzer (355ml)
Bon Jak Grapefruit Seltzer (355ml)
Bon Jak Mango Seltzer (355ml)

The products are expected to be listed to the Société québécoise du cannabis (“SQDC”) effective September 12, 2022, and expected to be distributed through the SQDC retail and online channels.

Tyler Robson, Chief Executive Officer of The Valens Company, said, “The agreement with the SQDC reflects our commitment to the Quebec market and more importantly Quebec consumers. We have been listening to feedback and understand the importance of delivering unique, regionally focused products under a relatable and socially conscious brand at competitive price points. Importantly, we believe our innovation and manufacturing capabilities uniquely position us for success in Quebec and we will continue to invest in this strategic market.”

At Valens, it’s Personal.

Notice regarding Forward Looking Statements

All information included in this press release, including any information as to the future financial or operating performance and other statements of The Valens Company that express management’s expectations or estimates of future performance, other than statements of historical fact, constitute forward-looking information or forward-looking statements within the meaning of applicable securities laws and are based on expectations, estimates and projections as of the date hereof. Forward-looking statements are included for the purpose of providing information about management’s current expectations and plans relating to the future. Wherever possible, words such as “plans”, “expects”, “scheduled”, “trends”, “forecasts”, “future”, “indications”, “potential”, “estimates”, “predicts”, “anticipate”, “to establish”, “believe”, “intend”, “ability to”, or statements that certain actions, events or results “may”, “should”, “could”, “would”, “might”, “will”, or are “likely” to be taken, occur or be achieved, or the negative of these words or other variations thereof, have been used to identify such forward-looking information. Specific forward-looking statements include, without limitation, statements regarding the ability to regain compliance with the Nasdaq Listing Rules, and anticipated courses of action.

The risks and uncertainties that may affect forward-looking statements include, among others, the inability to meet the Minimum Bid Requirement or comply with Nasdaq’s other listing standards within the prescribed time period, which could result in the delisting of the common shares, Canadian regulatory risk, Australian regulatory risk, U.S. regulatory risk, U.S. border crossing and travel bans, the uncertainties, effects of and responses to the COVID-19 pandemic, reliance on licenses, expansion of facilities, competition, dependence on supply of cannabis and reliance on other key inputs, dependence on senior management and key personnel, general business risk and liability, regulation of the cannabis industry, change in laws, regulations and guidelines, compliance with laws, limited operating history, vulnerability to rising energy costs, unfavorable publicity or consumer perception, product liability, risks related to intellectual property, product recalls, difficulties with forecasts, management of growth and litigation, many of which are beyond the control of The Valens Company. For a more comprehensive discussion of the risks faced by The Valens Company, and which may cause the actual financial results, performance or achievements of The Valens Company to be materially different from estimated future results, performance or achievements expressed or implied by forward-looking information or forward-looking statements, please refer to The Valens Company’s latest Annual Information Form filed with Canadian securities regulatory authorities at www.sedar.com or on The Valens Company’s website at www.thevalenscompany.com. The risks described in such Annual Information Form are hereby incorporated by reference herein. Although the forward-looking statements contained herein reflect management’s current beliefs and reasonable assumptions based upon information available to management as of the date hereof, The Valens Company cannot be certain that actual results will be consistent with such forward-looking information. The Valens Company cautions you not to place undue reliance upon any such forward-looking statements. The Valens Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by applicable law. Nothing herein should be construed as either an offer to sell or a solicitation to buy or sell securities of The Valens Company.

(This information is primarily sourced from The Valens Company Inc.  Highly Capitalized has neither approved nor disapproved the contents of this news release. Read our Disclaimer here).

About the Author: HCN News Team

The News Team at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.

Share This Story, Choose Your Platform!